These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 37386350)

  • 1. Identification of Mulberrofuran as a potent inhibitor of hepatitis A virus 3C
    Sureshan M; Brintha S; Jothi A
    Mol Divers; 2024 Jun; 28(3):1609-1628. PubMed ID: 37386350
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification and biochemical characterization of DC07090 as a novel potent small molecule inhibitor against human enterovirus 71 3C protease by structure-based virtual screening.
    Ma GH; Ye Y; Zhang D; Xu X; Si P; Peng JL; Xiao YL; Cao RY; Yin YL; Chen J; Zhao LX; Zhou Y; Zhong W; Liu H; Luo XM; Chen LL; Shen X
    Eur J Med Chem; 2016 Nov; 124():981-991. PubMed ID: 27776325
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Potential Novel Thioether-Amide or Guanidine-Linker Class of SARS-CoV-2 Virus RNA-Dependent RNA Polymerase Inhibitors Identified by High-Throughput Virtual Screening Coupled to Free-Energy Calculations.
    Jukič M; Janežič D; Bren U
    Int J Mol Sci; 2021 Oct; 22(20):. PubMed ID: 34681802
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dual modes of modification of hepatitis A virus 3C protease by a serine-derived beta-lactone: selective crystallization and formation of a functional catalytic triad in the active site.
    Yin J; Bergmann EM; Cherney MM; Lall MS; Jain RP; Vederas JC; James MN
    J Mol Biol; 2005 Dec; 354(4):854-71. PubMed ID: 16288920
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of FDA approved drugs against SARS-CoV-2 RNA dependent RNA polymerase (RdRp) and 3-chymotrypsin-like protease (3CLpro), drug repurposing approach.
    Molavi Z; Razi S; Mirmotalebisohi SA; Adibi A; Sameni M; Karami F; Niazi V; Niknam Z; Aliashrafi M; Taheri M; Ghafouri-Fard S; Jeibouei S; Mahdian S; Zali H; Ranjbar MM; Yazdani M
    Biomed Pharmacother; 2021 Jun; 138():111544. PubMed ID: 34311539
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Assessing activity of Hepatitis A virus 3C protease using a cyclized luciferase-based biosensor.
    Zhou J; Wang D; Xi Y; Zhu X; Yang Y; Lv M; Luo C; Chen J; Ye X; Fang L; Xiao S
    Biochem Biophys Res Commun; 2017 Jul; 488(4):621-627. PubMed ID: 28501618
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis, delivery, and molecular docking of fused quinolines as inhibitor of Hepatitis A virus 3C proteinase.
    Jorshari MR; Mamaghani M; Jahanshahi P
    Sci Rep; 2021 Sep; 11(1):18970. PubMed ID: 34556768
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Toward development of generic inhibitors against the 3C proteases of picornaviruses.
    Banerjee K; Bhat R; Rao VUB; Nain A; Rallapalli KL; Gangopadhyay S; Singh RP; Banerjee M; Jayaram B
    FEBS J; 2019 Feb; 286(4):765-787. PubMed ID: 30461192
    [TBL] [Abstract][Full Text] [Related]  

  • 9. New 4-phenylcoumarin derivatives as potent 3C protease inhibitors: Design, synthesis, anti-HAV effect and molecular modeling.
    Kassem AF; Batran RZ; Abbas EMH; Elseginy SA; Shaheen MNF; Elmahdy EM
    Eur J Med Chem; 2019 Apr; 168():447-460. PubMed ID: 30844608
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of Potential Anti-Hepatitis A Virus 3C Protease Inhibitors Using Molecular Docking.
    Sasaki-Tanaka R; Nagulapalli Venkata KC; Okamoto H; Moriyama M; Kanda T
    Int J Mol Sci; 2022 May; 23(11):. PubMed ID: 35682728
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multiple virtual screening approaches for finding new hepatitis C virus RNA-dependent RNA polymerase inhibitors: structure-based screens and molecular dynamics for the pursue of new poly pharmacological inhibitors.
    Elhefnawi M; ElGamacy M; Fares M
    BMC Bioinformatics; 2012; 13 Suppl 17(Suppl 17):S5. PubMed ID: 23282180
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Functional binding of hexanucleotides to 3C protease of hepatitis A virus.
    Blaum BS; Wünsche W; Benie AJ; Kusov Y; Peters H; Gauss-Müller V; Peters T; Sczakiel G
    Nucleic Acids Res; 2012 Apr; 40(7):3042-55. PubMed ID: 22156376
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Conformational Ensemble of the Poliovirus 3CD Precursor Observed by MD Simulations and Confirmed by SAXS: A Strategy to Expand the Viral Proteome?
    Moustafa IM; Gohara DW; Uchida A; Yennawar N; Cameron CE
    Viruses; 2015 Nov; 7(11):5962-86. PubMed ID: 26610545
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Discovery of Potential Inhibitors for RNA-Dependent RNA Polymerase of Norovirus: Virtual Screening, and Molecular Dynamics.
    Ebenezer O; Jordaan MA; Damoyi N; Shapi M
    Int J Mol Sci; 2020 Dec; 22(1):. PubMed ID: 33375298
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phytochemicals: Promising Inhibitors of Human Rhinovirus Type 14 3C Protease as a Strategy to Fight the Common Cold.
    Tsilimingkra NT; Papaneophytou C
    Curr Top Med Chem; 2024; 24(15):1343-1358. PubMed ID: 38698747
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Heteroaromatic ester inhibitors of hepatitis A virus 3C proteinase: Evaluation of mode of action.
    Huitema C; Zhang J; Yin J; James MN; Vederas JC; Eltis LD
    Bioorg Med Chem; 2008 May; 16(10):5761-77. PubMed ID: 18407505
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hepatitis A virus proteinase 3C binding to viral RNA: correlation with substrate binding and enzyme dimerization.
    Peters H; Kusov YY; Meyer S; Benie AJ; Bäuml E; Wolff M; Rademacher C; Peters T; Gauss-Müller V
    Biochem J; 2005 Jan; 385(Pt 2):363-70. PubMed ID: 15361063
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An episulfide cation (thiiranium ring) trapped in the active site of HAV 3C proteinase inactivated by peptide-based ketone inhibitors.
    Yin J; Cherney MM; Bergmann EM; Zhang J; Huitema C; Pettersson H; Eltis LD; Vederas JC; James MN
    J Mol Biol; 2006 Aug; 361(4):673-86. PubMed ID: 16860823
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Natural Phytochemicals, Luteolin and Isoginkgetin, Inhibit 3C Protease and Infection of FMDV, In Silico and In Vitro.
    Theerawatanasirikul S; Thangthamniyom N; Kuo CJ; Semkum P; Phecharat N; Chankeeree P; Lekcharoensuk P
    Viruses; 2021 Oct; 13(11):. PubMed ID: 34834926
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In silico structural elucidation of the rabies RNA-dependent RNA polymerase (RdRp) toward the identification of potential rabies virus inhibitors.
    Kiriwan D; Choowongkomon K
    J Mol Model; 2021 May; 27(6):183. PubMed ID: 34031746
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.